BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36812713)

  • 1. The emerging role of PPAR-alpha in breast cancer.
    Qian Z; Chen L; Liu J; Jiang Y; Zhang Y
    Biomed Pharmacother; 2023 May; 161():114420. PubMed ID: 36812713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
    Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
    Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver.
    Kersten S; Stienstra R
    Biochimie; 2017 May; 136():75-84. PubMed ID: 28077274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation.
    Kamarajugadda S; Becker JR; Hanse EA; Mashek DG; Mashek MT; Hendrickson AM; Mullany LK; Albrecht JH
    Oncotarget; 2016 Jul; 7(30):47674-47686. PubMed ID: 27351284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα.
    Ducheix S; Podechard N; Lasserre F; Polizzi A; Pommier A; Murzilli S; Di Lisio C; D'Amore S; Bertrand-Michel J; Montagner A; Pineau T; Loiseau N; Lobaccaro JM; Martin PG; Guillou H
    Biochimie; 2013 Mar; 95(3):556-67. PubMed ID: 23063693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARα at the crossroad of metabolic-immune regulation in cancer.
    Zeng W; Yin X; Jiang Y; Jin L; Liang W
    FEBS J; 2022 Dec; 289(24):7726-7739. PubMed ID: 34480827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation.
    Chang NW; Wu CT; Chen DR; Yeh CY; Lin C
    J Nutr Biochem; 2013 Jan; 24(1):274-81. PubMed ID: 22902323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisomal proliferator-activated receptor α-b deficiency induces the reprogramming of nutrient metabolism in zebrafish.
    Li LY; Lv HB; Jiang ZY; Qiao F; Chen LQ; Zhang ML; Du ZY
    J Physiol; 2020 Oct; 598(20):4537-4553. PubMed ID: 32710562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nonthiazolidinedione peroxisome proliferator-activated receptor α/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice.
    Jeong HW; Lee JW; Kim WS; Choe SS; Shin HJ; Lee GY; Shin D; Lee JH; Choi EB; Lee HK; Yon GH; Cho B; Kim HR; Choi SH; Chung YS; Park SB; Chung H; Ro S; Kim JB
    Mol Pharmacol; 2010 Nov; 78(5):877-85. PubMed ID: 20724462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer.
    Chandran K; Goswami S; Sharma-Walia N
    Oncotarget; 2016 Mar; 7(13):15577-99. PubMed ID: 26621841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARα/HNF4α interplay on diversified responsive elements. Relevance in the regulation of liver peroxisomal fatty acid catabolism.
    Chamouton J; Latruffe N
    Curr Drug Metab; 2012 Dec; 13(10):1436-53. PubMed ID: 22978398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
    Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?
    Gani OA
    Cardiovasc Diabetol; 2008 Mar; 7():6. PubMed ID: 18355413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.
    Huss JM; Torra IP; Staels B; Giguère V; Kelly DP
    Mol Cell Biol; 2004 Oct; 24(20):9079-91. PubMed ID: 15456881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic acidosis rewires cancer cell metabolism through PPARα signaling.
    Rolver MG; Holland LKK; Ponniah M; Prasad NS; Yao J; Schnipper J; Kramer S; Elingaard-Larsen L; Pedraz-Cuesta E; Liu B; Pardo LA; Maeda K; Sandelin A; Pedersen SF
    Int J Cancer; 2023 Apr; 152(8):1668-1684. PubMed ID: 36533672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha (PPARalpha) and athero-sclerosis.
    Gouni-Berthold I; Krone W
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):513-23. PubMed ID: 16503871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced peroxisome proliferator-activated receptor-α and bile acid nuclear receptor NR1H4/FXR may affect the hepatic immune microenvironment of biliary atresia.
    Ma Y; Lu L; Tan K; Li Z; Guo T; Wu Y; Wu W; Zheng L; Fan F; Mo J; Gong Z
    Front Immunol; 2022; 13():875593. PubMed ID: 36090996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peroxisome proliferator-activated receptor-α enhances fatty acid oxidation in human adipocytes.
    Lee JY; Hashizaki H; Goto T; Sakamoto T; Takahashi N; Kawada T
    Biochem Biophys Res Commun; 2011 Apr; 407(4):818-22. PubMed ID: 21443859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branched-Chain Fatty Acids as Mediators of the Activation of Hepatic Peroxisome Proliferator-Activated Receptor Alpha by a Fungal Lipid Extract.
    Maheshwari G; Ringseis R; Wen G; Gessner DK; Rost J; Fraatz MA; Zorn H; Eder K
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32878262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.